載入...
The future of intravenous iron in nephrology
Management of anaemia in chronic kidney disease (CKD) patients can be difficult and expensive. The recently completed Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT), the largest double-blinded trial of erythropoiesis-stimulating agents (ESA) treatment in CKD to date, provides us...
Na minha lista:
| 發表在: | NDT Plus |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2011
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4813792/ https://ncbi.nlm.nih.gov/pubmed/27045558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndtplus/sfr040 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|